Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nevro

5.84
+0.0000
Volume:- -
Turnover:- -
Market Cap:221.21M
PE:-1.91
High:5.84
Open:5.84
Low:5.84
Close:5.84
Loading ...

Nevro Stock Falls Despite Q4 Sales Beat on Strong SCS Demand

Zacks
·
16 Jan

Nevro Corp: Balancing Short-Term Gains and Long-Term Uncertainties with a Hold Rating

TIPRANKS
·
14 Jan

Nevro Shares Rise 16% After 4Q, 2024 Revenue Guidance

Dow Jones
·
14 Jan

Nevro rises 10.9%

TIPRANKS
·
13 Jan

Nevro Corp Q4 REV View $100.2 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
13 Jan

Nevro Corp - Q4 2024 Worldwide Revenue Expected to Be $105M-$106M, Down 9%-10%

THOMSON REUTERS
·
13 Jan

Nevro Corp (NVRO) Receives a Hold from RBC Capital

TIPRANKS
·
08 Jan

What Makes Nevro (NVRO) a New Buy Stock

Zacks
·
25 Dec 2024

Truist Securities Adjusts Price Target on Nevro to $4.70 From $7, Keeps Hold Rating

MT Newswires Live
·
18 Dec 2024

Nevro price target lowered to $4.70 from $7 at Truist

TIPRANKS
·
18 Dec 2024

Nevro Is Maintained at Neutral by Citigroup

Dow Jones
·
12 Dec 2024

Nevro Corp (NVRO) Receives a Hold from Wells Fargo

TIPRANKS
·
11 Dec 2024

Zacks.com featured highlights include Stryve Foods, Nevro, Canoo, MSA Safety and VTEX

Zacks
·
11 Dec 2024

Bet on 5 Top-Ranked Stocks With Rising P/E

Zacks
·
10 Dec 2024

Nevro price target lowered to $4 from $7 at Canaccord

TIPRANKS
·
09 Dec 2024

Nevro Price Target Announced at $5.00/Share by Wells Fargo

Dow Jones
·
03 Dec 2024

Nevro Corp: Hold Rating Amid Market Challenges and Strategic Uncertainty

TIPRANKS
·
03 Dec 2024

Nevro resumed with an Equal Weight at Wells Fargo

TIPRANKS
·
03 Dec 2024

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos

Benzinga
·
03 Dec 2024

Morgan Stanley Downgrades Nevro to Underweight From Equalweight, Price Target is $4

MT Newswires Live
·
02 Dec 2024